Nasdaq
RAPP
Rapport Therapeutics, Inc.
- Health Care
- Listed 2024
- 1 day
- +9.2%
- 1 month
- +16.7%
- 1 year
- +217%
$46.35 · Mkt cap $2.22B
At the 6 Aug 2026 close
Nasdaq
Rapport Therapeutics, Inc.
$46.35 · Mkt cap $2.22B
At the 6 Aug 2026 close
Rapport Therapeutics, Inc. trades under the ticker RAPP on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2024. Its market capitalisation is $2.22B. The last closing price was $46.35, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +217%, and +16.7% over the past month. Returns are price returns and exclude dividends.
This page exists because RAPP is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.